Optimisation and Developability banner

Tailoring a molecule’s properties to improve its developability, half-life, and physico-chemical properties, will greatly improve its chances of success in the clinic, and is a critical first step to determining a molecule's druggability. The 14th Annual Optimisation & Developability conference will present strategies to optimise drug properties, assess and predict stability, aggregation and immunogenicity risk, by using a toolbox of molecule modeling, deep learning, in silico approaches, as well as the latest AI and machine learning methods.

For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com